vTv Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

vTv Therapeutics

30/03/2022 03:49

* vTv Therapeutics Inc  VTVT.OQ  reported a quarterly
adjusted
loss of 8 cents​​ per share for the quarter ended in December.
The mean expectation of two analysts for the quarter was for a
loss of 7 cents per share.
    * Revenue fell 99.9% to $9.00 thousand from a year ago; 
analysts
expected $1.00 million. 
    * vTv Therapeutics Inc's reported EPS for the quarter was a
loss
of 11 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * vTv Therapeutics Inc shares had fallen by 29.2% this
quarter.
    * The company reported a quarterly loss of $7.05 million.
    * Wall Street's median 12-month price target for vTv
Therapeutics
Inc is $6.75 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 30 at 02:49 a.m.  ​All
figures in US dollars unless otherwise stated